638PTwo Year Survival and Safety Update for Esophageal Squamous Cell Carcinoma Treated With Nivolumab (ATTRACTION-01/ONO-4538-07)

Annals of Oncology - United Kingdom
doi 10.1093/annonc/mdx369.022
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Three‐year Follow‐up Results From Phase II Studies of Nivolumab in Japanese Patients With Previously Treated Advanced Non‐small Cell Lung Cancer: Pooled Analysis of ONO‐4538‐05 and ONO‐4538‐06 Studies

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Five-Year Survival and Correlates Among Patients With Advanced Melanoma, Renal Cell Carcinoma, or Non–Small Cell Lung Cancer Treated With Nivolumab

JAMA Oncology
Cancer ResearchOncology
2019English

Tumour Infiltrating Lymphocytes Correlate With Improved Survival in Patients With Esophageal Squamous Cell Carcinoma

Scientific Reports
Multidisciplinary
2017English

Surgically Resected Esophageal Squamous Cell Carcinoma: Patient Survival and Clinicopathological Prognostic Factors

Scientific Reports
Multidisciplinary
2020English

HOXA13 Promotes Cancer Cell Growth and Predicts Poor Survival of Patients With Esophageal Squamous Cell Carcinoma

Cancer Research
Cancer ResearchOncology
2009English

Esophageal Squamous Cell Papilloma, Suspected of Squamous Cell Carcinoma.

Internal Medicine
Internal MedicineMedicine
1993English

Risk Factors Associated With Esophageal Fistula After Radiotherapy for Esophageal Squamous Cell Carcinoma

Journal of Cancer
Oncology
2020English

A Case of Long-Term Survival of an Esophageal Mixed Type Carcinoma of Neuroendocrine Carcinoma Accompanied by Squamous Cell Carcinoma, Treated With Neoadjuvant and Adjuvant Chemotherapy

Japanese Journal of Gastroenterological Surgery
SurgeryGastroenterology
2014English

Distinctive MicroRNA Profiles Relating to Patient Survival in Esophageal Squamous Cell Carcinoma

Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy